Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trospium chloride versus placebo for overactive bladder syndrome in adult women, with bladder function and cognitive assessment
ISRCTN17587199Phase 4Completed
- Sponsor
- Lviv Municipal Clinical Hospital No. 1
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in overactive bladder (OAB) comparing Trospium chloride with Placebo (2 arms). Primary endpoints: Change in Overactive Bladder Symptoms Score at 6 weeks and Change in Overactive Bladder Symptoms Bother at 6 weeks. Started Jan 2010; status: completed.
02
Drugs
trospium
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on ISRCTN17587199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17587199.